Compare NSIT & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSIT | NEOG |
|---|---|---|
| Founded | 1988 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.9B |
| IPO Year | 1996 | 1995 |
| Metric | NSIT | NEOG |
|---|---|---|
| Price | $107.10 | $8.96 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $116.25 | $10.67 |
| AVG Volume (30 Days) | 570.8K | ★ 2.3M |
| Earning Date | 05-07-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.97 | 0.02 |
| Revenue | ★ $8,247,180,000.00 | $894,661,000.00 |
| Revenue This Year | $3.79 | N/A |
| Revenue Next Year | $2.16 | N/A |
| P/E Ratio | ★ $106.29 | $467.75 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $63.62 | $4.53 |
| 52 Week High | $148.36 | $11.43 |
| Indicator | NSIT | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 83.34 | 49.47 |
| Support Level | $105.78 | $8.98 |
| Resistance Level | $111.54 | $10.12 |
| Average True Range (ATR) | 4.28 | 0.39 |
| MACD | 1.91 | 0.08 |
| Stochastic Oscillator | 97.04 | 62.74 |
Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, government agencies, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital workplace, cloud/data center transformation, IT modernization, Cyber Security and supply chain optimization solutions and services.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.